Skip to main content
Menu
US

HTRF Human CTLA4 / CD86 Binding Kit Standard

The human CTLA4/CD86 Standard is intended for use with the human CTLA4/CD86 biochemical binding kit.

Click to copy promo code to clipboard.
img-icon-save-10-black.svg

March lab savings - buy on Revvity.com or Revvity punchout to SAVE 10% with promo code!

MARCH10

Sale ends 3/24. Terms and conditions apply.

Feature Specification
Application Protein-Protein Interaction

The human CTLA4/CD86 Standard is intended for use with the human CTLA4/CD86 biochemical binding kit.

Click to copy promo code to clipboard.
img-icon-save-10-black.svg

March lab savings - buy on Revvity.com or Revvity punchout to SAVE 10% with promo code!

MARCH10

Sale ends 3/24. Terms and conditions apply.

Product Variant
Unit Size: 1 vial
Part #:
64CTLA86CDA
List Price
USD 381.48
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

This standard provides a way to quantify inhibition of the CTLA4/CD86 interaction.

Specifications

Application
Protein-Protein Interaction
Brand
HTRF
Detection Modality
HTRF
Product Group
Standard
Shipping Conditions
Shipped in Dry Ice
Target Class
Binding Assay
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Oncology & Inflammation
Unit Size
1 vial

Video gallery

Assay details

Technical specifications of the CTLA4/CD86 standard

A dose response curve for the standard using the conditions described for the kit gives an IC50 of 1.0 nM.

human-CTLA4-CD86-standard

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Flyer Icon
Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies

Scroll Icon